Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization.

Abstract

The antiangiogenic steroid AL-3789 may be a therapeutically useful angiostatic agent for corneal neovascularization and potentially could be effective in other ocular neovascular diseases.